Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with a ...

Intermittent preventive treatment in pregnant women; SP: Sulphadoxine–pyrimethamine. With malaria being one of the most significant causes of morbidity and mortality worldwide, prompt and ...

Malaria treatment and prophylaxis options in endemic and ... IPT in infants; IPTp: IPT in pregnant women.

Researchers enrolled 280 pregnant women with highly viremic HBV infection (HBV DNA, >200,000 IU/mL) to compare interventions for the prevention of mother-to-child transmission. Patients were randomly ...

June 12, 2023 — Women who used combined contraceptive ... was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global ...

The results are striking: both interventions demonstrated remarkable protective efficacy against confirmed malaria cases—94% (hazard ratio ... piperaquine for intermittent preventive treatment in ...

Findings to date Pregnant women were identified at a mean of 6.9 weeks of gestation (wg). Preliminary results confirmed the high prevalence of malaria in the first trimester of pregnancy, with more ...

Tafenoquine is currently approved for malaria prophylaxis but has not yet been proven safe or effective for babesiosis. The study is supported by the U.S. Army Medical & Materiel Development Activity.

Israel has inflicted “serious and sometimes life-threatening danger” on pregnant and postpartum women and girls in Gaza over ...

If you are pregnant or nursing, talk with your health care professional about whether to enroll in pregnancy safety or ...